Retraction Note: NF-κB activation impairs somatic cell reprogramming in ageing (Nature Cell Biology, (2015), 17, 8, (1004-1013), 10.1038/ncb3207);NF-κB activation impairs somatic cell reprogramming in ageing

Nature Cell Biology

Volumn 17, Issue 8, 2015, Pages 1004-1013

  Soria Valles, Clara ^a   Osorio, Fernando G ^a   Gutiérrez Fernández, Ana ^a   De Los Angeles, Alejandro ^b   Bueno, Clara ^c   Menéndez, Pablo ^c,d   Martín Subero, José I ^c   Daley, George Q ^b,c,e   Freije, José M P ^a   López Otín, Carlos ^a  

^a DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF BARCELONA   (Spain)

^d INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

^e HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BARRIER TO AUTOINTEGRATION FACTOR; DOT1L PROTEIN; HISTONE METHYLTRANSFERASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; UNCLASSIFIED DRUG; DOT1L PROTEIN, HUMAN; DOT1L PROTEIN, MOUSE; MEMBRANE PROTEIN; METALLOPROTEINASE; METHYLTRANSFERASE; ZMPSTE24 PROTEIN, MOUSE;

AGED; AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL AGING; CELL DIFFERENTIATION; CHILD; CONTROLLED STUDY; DOWN REGULATION; ENZYME INHIBITION; FEMALE; FIBROBLAST; GENE REPRESSION; HUMAN; HUMAN CELL; HUTCHINSON GILFORD PROGERIA SYNDROME; IN VIVO STUDY; LIFESPAN; MALE; MOUSE; NESTOR GUILLERMO PROGERIA SYNDROME; NONHUMAN; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELL; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGERIA; SCHOOL CHILD; SOMATIC CELL; TRANSCRIPTION INITIATION; VERY ELDERLY; AGE; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CASE CONTROL STUDY; CELL LINE; CELL PROLIFERATION; DEFICIENCY; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETIC TRANSFECTION; GENETICS; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; PHENOTYPE; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TIME;

AGE FACTORS; AGED, 80 AND OVER; AGING; ANIMALS; CASE-CONTROL STUDIES; CELL AGING; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CELLULAR REPROGRAMMING; DISEASE MODELS, ANIMAL; FEMALE; FIBROBLASTS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MALE; MEMBRANE PROTEINS; METALLOENDOPEPTIDASES; METHYLTRANSFERASES; MICE, INBRED C57BL; MICE, KNOCKOUT; NF-KAPPA B; PHENOTYPE; PROGERIA; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFECTION;

EID: 84938750948     PISSN: 14657392     EISSN: 14764679     Source Type: Journal    
DOI: 10.1038/s41556-018-0259-0     Document Type: Erratum

References (59)

1. Mahmoudi, S. & Brunet, A. Aging and reprogramming: a two-way street. Curr. Opin. Cell Biol. 24, 744-756 (2012
2. Lopez-Otin, C., Blasco, M. A., Partridge, L., Serrano, M. & Kroemer, G. The hallmarks of aging. Cell 153, 1194-1217 (2013
3. Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-872 (2007
4. Robinton, D. A. & Daley, G. Q. The promise of induced pluripotent stem cells in research and therapy. Nature 481, 295-305 (2012
5. Li, H. et al. The Ink4/Arf locus is a barrier for iPS cell reprogramming. Nature 460, 1136-1139 (2009
6. Wang, B. et al. Reprogramming efficiency and quality of induced Pluripotent Stem Cells (iPSCs) generated from muscle-derived fibroblasts of mdx mice at different ages. PLoS Curr. 3, RRN1274 (2011
7. Kim, K. et al. Epigenetic memory in induced pluripotent stem cells. Nature 467, 285-290 (2010
8. Marion, R. M. et al. A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity. Nature 460, 1149-1153 (2009
9. Banito, A. et al. Senescence impairs successful reprogramming to pluripotent stem cells. Genes Dev. 23, 2134-2139 (2009
10. Marion, R. M. et al. Telomeres acquire embryonic stem cell characteristics in induced pluripotent stem cells. Cell Stem Cell 4, 141-154 (2009
11. Suhr, S. T. et al. Mitochondrial rejuvenation after induced pluripotency. PLoS ONE 5, e14095 (2010
12. Kawamura, T. et al. Linking the p53 tumour suppressor pathway to somatic cell reprogramming. Nature 460, 1140-1144 (2009
13. Lapasset, L. et al. Rejuvenating senescent and centenarian human cells by reprogramming through the pluripotent state. Genes Dev. 25, 2248-2253 (2011
14. Rando, T. A. & Chang, H. Y. Aging, rejuvenation, and epigenetic reprogramming: resetting the aging clock. Cell 148, 46-57 (2012
15. Freije, J. M. & Lopez-Otin, C. Reprogramming aging and progeria. Curr. Opin. Cell Biol. 24, 757-764 (2012
16. Schreiber, K. H. & Kennedy, B. K. When lamins go bad: nuclear structure and disease. Cell 152, 1365-1375 (2013
17. Osorio, F. G. et al. Splicing-directed therapy in a new mouse model of human accelerated aging. Sci. Transl. Med. 3, 106ra107 (2011
18. Gordon, L. B., Rothman, F. G., Lopez-Otin, C. & Misteli, T. Progeria: a paradigm for translational medicine. Cell 156, 400-407 (2014
19. Miller, J. D. et al. Human iPSC-based modeling of late-onset disease via progerininduced aging. Cell Stem Cell 13, 691-705 (2013
20. Zhang, J. et al. A human iPSC model of Hutchinson Gilford Progeria reveals vascular smooth muscle and mesenchymal stem cell defects. Cell Stem Cell 8, 31-45 (2011
21. Liu, G. H. et al. Recapitulation of premature ageing with iPSCs from Hutchinson-Gilford progeria syndrome. Nature 472, 221-225 (2011
22. Nissan, X. et al. Unique preservation of neural cells in Hutchinson-Gilford progeria syndrome is due to the expression of the neural-specific miR-9 microRNA. Cell Rep. 2, 1-9 (2012
23. Scaffidi, P. & Misteli, T. Lamin A-dependent nuclear defects in human aging. Science 312, 1059-1063 (2006
24. Puente, X. S. et al. Exome sequencing and functional analysis identifies BANF1 mutation as the cause of a hereditary progeroid syndrome. Am. J. Hum. Genet. 88, 650-656 (2011
25. Cabanillas, R. et al. Nestor-Guillermo progeria syndrome: a novel premature aging condition with early onset and chronic development caused by BANF1 mutations. Am. J. Med. Genet. A 155A, 2617-2625 (2011
26. Margalit, A., Brachner, A., Gotzmann, J., Foisner, R. & Gruenbaum, Y. Barrier-To-Autointegration factor-A BAFfling little protein. Trends Cell Biol. 17, 202-208 (2007
27. Buganim, Y., Faddah, D. A. & Jaenisch, R. Mechanisms and models of somatic cell reprogramming. Nat. Rev. Genet. 14, 427-439 (2013
28. Liang, G. & Zhang, Y. Genetic and epigenetic variations in iPSCs: potential causes and implications for application. Cell Stem Cell 13, 149-159 (2013
29. Soldner, F. & Jaenisch, R. Medicine. iPSC disease modeling. Science 338, 1155-1156 (2012
30. Smahi, A. et al. Genomic rearrangement in NEMO impairs NF-B activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium. Nature 405, 466-472 (2000
31. Luningschror, P., Stocker, B., Kaltschmidt, B. & Kaltschmidt, C. miR-290 cluster modulates pluripotency by repressing canonical NF-B signaling. Stem Cells 30, 655-664 (2012
32. Takase, O. et al. The role of NF-B signaling in the maintenance of pluripotency of human induced pluripotent stem cells. PLoS ONE 8, e56399 (2013
33. Torres, J. & Watt, F. M. Nanog maintains pluripotency of mouse embryonic stem cells by inhibiting NF-B and cooperating with Stat3. Nat. Cell Biol. 10, 194-201 (2008
34. Kuo, H. P. et al. Epigenetic roles of MLL oncoproteins are dependent on NF-B. Cancer Cell 24, 423-437 (2013
35. Wang, H. et al. NF-B regulation of YY1 inhibits skeletal myogenesis through transcriptional silencing of myofibrillar genes. Mol. Cell. Biol. 27, 4374-4387 (2007
36. Onder, T. T. et al. Chromatin-modifying enzymes as modulators of reprogramming. Nature 483, 598-602 (2012
37. Coppe, J. P., Desprez, P. Y., Krtolica, A. & Campisi, J. The senescence-Associated secretory phenotype: the dark side of tumor suppression. Annu. Rev. Pathol. 5, 99-118 (2010
38. Pendas, A. M. et al. Defective prelamin A processing and muscular and adipocyte alterations in Zmpste24 metalloproteinase-deficient mice. Nat. Genet. 31, 94-99 (2002
39. Varela, I. et al. Combined treatment with statins and aminobisphosphonates extends longevity in a mouse model of human premature aging. Nat. Med. 14, 767-772 (2008
40. Osorio, F. G. et al. Nuclear lamina defects cause ATM-dependent NF-B activation and link accelerated aging to a systemic inflammatory response. Genes Dev. 26, 2311-2324 (2012
41. Cau, P. et al. Nuclear matrix, nuclear envelope and premature aging syndromes in a translational research perspective. Semin. Cell Dev. Biol. 29, 125-147 (2014
42. Adler, A. S. et al. Motif module map reveals enforcement of aging by continual NF-B activity. Genes Dev. 21, 3244-3257 (2007
43. Tilstra, J. S. et al. NF-B inhibition delays DNA damage-induced senescence and aging in mice. J. Clin. Invest. 122, 2601-2612 (2012
44. Jurk, D. et al. Chronic inflammation induces telomere dysfunction and accelerates ageing in mice. Nat. Commun. 2, 4172 (2014
45. Baker, D. J. et al. Clearance of p16Ink4a-positive senescent cells delays ageingassociated disorders. Nature 479, 232-236 (2011
46. Kawahara, T. L. et al. SIRT6 links histone H3 lysine 9 deacetylation to NF-B-dependent gene expression and organismal life span. Cell 136, 62-74 (2009
47. Osorio, F. G. et al. Nuclear envelope alterations generate an aging-like epigenetic pattern in mice deficient in Zmpste24 metalloprotease. Aging Cell 9, 947-957 (2010
48. Han, S. & Brunet, A. Histone methylation makes its mark on longevity. Trends Cell Biol. 22, 42-49 (2012
49. De Vos, D. et al. Progressive methylation of ageing histones by Dot1 functions as a timer. EMBO Rep. 12, 956-962 (2011
50. Chien, Y. et al. Control of the senescence-Associated secretory phenotype by NF-B promotes senescence and enhances chemosensitivity. Genes Dev. 25, 2125-2136 (2011
51. Baker, D. J., Weaver, R. L. & Van Deursen, J. M. p21 both attenuates and drives senescence and aging in BubR1 progeroid mice. Cell Rep. 3, 1164-1174 (2013
52. Krishnan, V. et al. Histone H4 lysine 16 hypoacetylation is associated with defective DNA repair and premature senescence in Zmpste24-deficient mice. Proc. Natl Acad. Sci. USA 108, 12325-12330 (2011
53. Daigle, S. R. et al. Potent inhibition of DOT1L as treatment of MLL-fusion leukemia. Blood 122, 1017-1025 (2013
54. Varela, I. et al. Accelerated ageing in mice deficient in Zmpste24 protease is linked to p53 signalling activation. Nature 437, 564-568 (2005
55. Soria-Valles, C. et al. Somatic cell reprogramming using NF-B inhibitory strategies. Nat. Protoc. Exch. http: //dx.doi.org/10.1038/protex.2015.057 (2015
56. Sanchez, L. et al. Enrichment of human ESC-derived multipotent mesenchymal stem cells with immunosuppressive and anti-inflammatory properties capable to protect against experimental inflammatory bowel disease. Stem Cells 29, 251-262 (2011
57. Liu, B. et al. Resveratrol rescues SIRT1-dependent adult stem cell decline and alleviates progeroid features in laminopathy-based progeria. Cell Metab. 16, 738-750 (2012
58. Xu, C. et al. Immortalized fibroblast-like cells derived from human embryonic stem cells support undifferentiated cell growth. Stem Cells 22, 972-980 (2004
59. Doi, A. et al. Differential methylation of tissue-And cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nat. Genet. 41, 1350-1353 (2009